Article

Use of real-world evidence in regulatory decisions for traditional Chinese medicine---Current status and future

2023-07-10

Abstract excerpt

Traditional Chinese medicine(TCM) is a valuable resource unique to China with a long history of human use and clinical practice, which can be analyzed to generate real-world evidence(RWE). The Chinese government has been actively promoting regulatory reform that is in line with the characteristics of TCM, optimizing the clinical evidence system for TCM, and exploring the important role of RWE in supporting the dev...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4130d126-ec95-5c06-9328-93b954faf37b
DOI: 10.22541/au.168899043.39860443/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Use of real-world evidence in regulatory decisions for traditional Chinese medicine---Current status and futureDOI 10.22541/au.168899043.39860443/v1Read

Trend of clinical trials of new drugs for rare diseases in China in recent 10 yearsSemantic proximity Read

Real World Evidence – Current Developments and PerspectivesSemantic proximity Read

Characteristics of registered systematic reviews on traditional Chinese medicine for COVID-19Semantic proximity Read

Systematic Analysis and Quality Evaluation for Pharmacoeconomic Studies on Traditional Chinese MedicinesSemantic proximity Read

Ensuring Quality Medicine: A Comprehensive Overview of EMA and DGDA's History, Structure, and Functions.Semantic proximity Read

TCMM: A Unified Database for Traditional Chinese Medicine Modernization and Therapeutic InnovationsSemantic proximity Read

Traditional Chinese medicine: A Bayesian network model of public awareness, usage determinants, and perception of scientific support in AustriaSemantic proximity Read

The impact of National Centralized Drug Procurement policy on the use of policy-related original and generic drugs in public medical institutions in China: A difference-in-difference analysis based on national databaseSemantic proximity Read

Randomized Controlled Trials Versus Real World Evidence: Neither Magic Nor Myth.Semantic proximity Read

Analysis of Methodological Quality of The Process of Moving From Evidence to Recommendations in Chinese Clinical Practice Guidelines Between 2010 and 2020: A Cross-Sectional StudySemantic proximity Read

Analysis of Patient Access to Orphan Drugs in TurkeySemantic proximity Read

Current Situation of Clinical Trials of Drugs for Children's Indications in ChinaSemantic proximity Read